AT-752

Atea dumps dengue drug as 'unevaluable' endpoint causes timelines, forecast costs to spiral
Fierce Biotech
Wed, 03/1/23 - 06:52 pm
Atea Pharmaceuticals
dengue
clinical trials
AT-752